NJBIZ, New Jersey’s leading business journal, provides 24/7 business news coverage and events honoring top business professionals.

A Florida hospital lost efforts to revive allegations that C.R. Bard Inc. and Bard Access Systems Inc. unlawfully tied catheter sales to another medical device after the Tenth Circuit affirmed a lower ...

NEW YORK (Reuters) - U.S. medical equipment supplier Becton Dickinson and Co (BDX.N) will acquire C R Bard Inc (BCR.N), in a $24 billion (£18.72 billion) cash-and-stock deal, adding Bard's devices to ...

Medical device company C.R. Bard (BCR +0.00%) plans to acquire Medafor, a privately held developer and supplier of plant-based hemostatic agents such as Arista MPH Hemostat, which can control bleeding ...

This post is from Forbes partner Narrative Science. Wall Street is expecting higher profit for C.R. Bard (BCR) when the company reports its third quarter results. The consensus estimate is calling for ...

Shares of C.R. Bard Inc.BCR climbed 2.1% to $190.22, following the signing of a definitive agreement to acquire Kobayashi Pharmaceutical's 50% stake in Medicon. Medicon is a joint venture formed by ...

This post has been updated to include information from a conference call with analysts about the deal. Another week, another ginormous medical device deal. This time it is Becton Dickinson which has ...

FRANKLIN LAKES, N.J. (AP) -- Medical technology firm Becton, Dickinson and Co. says it has reached an agreement to buy competitor C.R. Bard Inc. in a cash-and-stock deal worth $24 billion. The deal ...

Analysts expect higher profit for C.R. Bard when the company reports its first quarter results on Thursday, April 23, 2015. The consensus estimate is calling for profit of $2.07 a share, reflecting a ...